Treatment options for primary constipation

Current Treatment Options in Gastroenterology

Volumn 7, Issue 3, 2004, Pages 225-233

  Pampati, Vijayamalini ^a   Fogel, Ronald ^a  

^a HENRY FORD HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRAQUINONE DERIVATIVE; ANTICOAGULANT AGENT; BISACODYL; CASCARA; CASTOR OIL; DIGITALIS GLYCOSIDE; DOCUSATE SODIUM; GLYCEROL; HISTAMINE H2 RECEPTOR ANTAGONIST; ISPAGULA; LACTULOSE; LAXATIVE; MACROGOL; MAGNESIUM CITRATE; MAGNESIUM HYDROXIDE; MAGNESIUM SULFATE; METHYLCELLULOSE; MINERAL OIL; PHENOTHIAZINE; POLYCARBOPHIL CALCIUM; PROTON PUMP INHIBITOR; SALICYLIC ACID DERIVATIVE; SENNA EXTRACT; SEROTONIN 4 AGONIST; SODIUM CHLORIDE; SODIUM DIHYDROGEN PHOSPHATE; SORBITOL; TEGASEROD; TETRACYCLINE; UNINDEXED DRUG;

ABDOMINAL CRAMP; ABDOMINAL DISCOMFORT; ACIDOSIS; ANAPHYLAXIS; ANOREXIA; ASPIRATION PNEUMONIA; CLINICAL TRIAL; COLON SURGERY; CONFUSION; CONSTIPATION; COST EFFECTIVENESS ANALYSIS; DEHYDRATION; DIAPHORESIS; DIETARY FIBER; DRUG ABSORPTION; DRUG APPROVAL; DRUG BINDING; DRUG BIOAVAILABILITY; DRUG CONTRAINDICATION; DRUG HYPERSENSITIVITY; DRUG INHIBITION; DRUG MECHANISM; DYSPNEA; ELECTROLYTE DISTURBANCE; ESOPHAGUS OBSTRUCTION; FEEDBACK SYSTEM; FLATULENCE; FOREIGN BODY REACTION; GERIATRIC PATIENT; HEART ARRHYTHMIA; HEART BLOCK; HEART DISEASE; HOT FLUSH; HUMAN; HYPERMAGNESEMIA; HYPERPHOSPHATEMIA; HYPERTENSION; HYPOCALCEMIA; HYPOREFLEXIA; HYPOTENSION; INTESTINE OBSTRUCTION; INTESTINE TRANSIT TIME; KIDNEY DISEASE; MALABSORPTION; MELANOSIS; PARALYSIS; PARESTHESIA; RESPIRATION DEPRESSION; REVIEW; SEIZURE; STOMACH EMPTYING; SYMPTOMATOLOGY; TETANY; TREATMENT FAILURE;

EID: 3142596398     PISSN: 10928472     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11938-004-0043-z     Document Type: Review

References (41)

1. Lembo A, Camilleri M: Chronic constipation. N Engl J Med 2003, 349:1360-1368.
2. Stewart RB, Moore MT, Marks RG, et al.: Correlates of constipation in an ambulatory elderly population Am. J Gastroenterol 1992, 87:859-864.
3. Hale WE, Perkins LL, May FE, et al.: Symptom prevalence in the elderly. An evalution of age, sex, disease, and medication use. J Am Geriatr Soc 1986, 34:335-340.
4. Whitehead WE, Drinkwater D, Cheskin LJ, et al.: Constipation in the elderly living at home. Definition, prevalence, and relationship to lifestyle and health status. J Am Geriatr Soc 1989, 37:423-429.
5. Dukas L, Willett WC, Giovannucci EL: Association between physical activity, fiber intake, and other lifestyle variables and constipation in a study of women. Am J Gastroenterol 2003, 98:1790-1796.
6. Bingham SA, Cummings JH: Effect of exercise and physical fitness on large intestinal function. Gastroenterology 1989, 97:1389-1399.
7. Oettle GJ: Effect of moderate exercise on bowel habit. Gut 1991, 32:941-944.
8. Coenen C, Wegener M, Wedmann B, et al.: Does physical exercise influence bowel transit time in healthy young men?. Am J Gastroenterol 1992, 87:292-295.
9. Velio P, Assotti G: Chronic idiopathic constipation: pathophysiology and treatment. J Clin Gastroenterol 1996, 22:190-196.
10. Chung BD, Parekh U, Sellin JH: Effect of increased fluid intake on stool output in normal healthy volunteers. J Clin Gastroenterol 1999, 28:29-32.
11. Marlett JA, McBurney MI, Slavin JL: Position of the ADA: health implications of dietary fiber. J Am Dietetic Assoc 2002, 102:993-1000.
12. Dietary Functional and Total Fiber in Dietary Reference Intakes for Energy, Carbohydrates, Fiber, Fat, Fatty Acids, Cholesterol, Protein and Amino Acids. Washington, DC: National Academies Press; 2003:265-334.
13. Voderhozer WA, Schatke W, Muhldorfer BE, et al.: Clinical response to dietary fiber treatment of chronic constipation. Am J Gastroenterol 1997, 92:95-98.
14. Xing JH, Soffer EE: Adverse effects of laxatives. Dis Colon Rectum 2001, 44:1201-1209.
15. DiPalma JA, DeRidder PH, Orlando RC, et al.: A randomized, placebo-controlled, multicenter study of the safety and efficacy of a new polyethylene glycol laxative. Am J Gastroenterol 2000, 95:446-450.
16. Wald A: Is chronic use of stimulant laxatives harmful to the colon? J Clin Gastroenterol 2003, 36:386-389.
17. Joo JS, Ehrenpreis ED, Gonzalez L, et al.: Alterations in colonic anatomy induced by chronic stimulant laxatives: the cathartic colon revisited. J Clin Gastroenterol 1998, 26:283-286.
18. Muller-Lissner S: What has happened to the cathartic colon? Gut 1996, 39:486-488.
19. Sonnenberg A, Muller AD: Constipation and cathartics as risk factors of colorectal cancer; a meta-analysis. Pharmacology 1993, 47(suppl 1):224-233.
20. Wagstaff AJ, Frampton JE, Croom KF: Tegaserod. A review of its use in the management of Irritable Bowel Syndrome with constipation in women. Drugs 2003, 63:1101-1120.
21. Bertoli R, Girardin F, Russmann S, Lauterburg BH: Raynaud's phenomenon induced by drugs acting on neurotransmission: two cases under reboxetine and one under tegaserod. Eur J Clin Pharmacol 2003, 58:717-721.
22. Muller-Lissner SA, Fumagalli I, Bardahn KD, et al.: Tegaserod, a 5HT4 receptor partial agonist, relieves symptoms in irritable bowel syndrome patients with abdominal pain, bloating and constipation. Aliment Pharmacol Ther 2001, 15:1655-1666.
23. Novick J, Miner P, Krause R, et al.: A randomized, double-blind, placebo-controlled trial of tegaserod in female patients suffering from irritable bowel syndrome with constipation. Aliment Pharmacol Ther 2002, 16:1877-1888.
24. Kellow JI, Lee OY, Chang FY, et al.: An Asia-Pacific, double-blind, placebo-controlled, randomized study to evaluate the efficacy, safety, and tolerability of tegaserod in patients with irritable bowel syndrome. Gut 2003, 52:671-676.
25. Roarty TP, Weber F, Soykan I, McCallum RW: Misoprostil in the treatment of chronic refractory constipation: results of a long-term open label trial. Aliment Pharmacol Ther 1997, 11:1059-1066.
26. Lubowski DZ, Chen FC, Kennedy ML, King DW: Results of colectomy for severe slow transit constipation. Dis Colon Rectum 1996, 39:23-29.
27. Nyam D, Pemberton JH, Ilstrup DM, Rath DM: Long-term results of surgery for chronic constipation. Dis Colon Rectum 1997, 40:273-279.
28. Knowles CH, Scott M, Lunniss PJ: Outcome of colectomy for slow transit constipation. Ann Surg 1999, 230:627-638.
29. Pfeifer J, Agachan F, Wexner SD: Surgery for constipation: a review. Dis Colon Rectum 1996, 39:444-460.
30. FitzHarris GP, Garcia-Aguilar J, Parker SC, et al.: Quality of life after subtotal colectomy for slow-transit constipation: both quality and quantity count. Dis Colon Rectum 2003, 46:433-440.
31. Chiotakakou-Faliakou E, Kamm MA, Roy AJ, et al.: Biofeedback provides long-term benefit for patients with intractable slow and normal transit constipation. Gut 1998, 42:517-521.
32. Emmanuel AV, Kamm MA: Response to a behavioral treatment, biofeedback, in constipated patients is associated with improved gut transit and autonomic innervation. Gut 2001, 49:214-219.
33. Heymen SM, Jones KR, Scarlett Y, Whitehead WE: Biofeedback treatment of constipation: A critical review. Dis Colon Rectum 2003, 46:1208-1217.
34. Coulie B, Szarka LA, Camilleri M, et al.: Recombinant human neurotropic factors accelerate colonic transitand relieve constipation in humans. Gastroenterology 2000, 119:41-50.
35. Parkman HP, Rao SS, Reynolds JC, et al.: Neurotropin-3 improves functional constipation. Am J Gastroenterol 2003, 98:1338-1347.
36. Jin JG, Foxx-Ornstein AE, Grider JR: Propulsion in guinea pig colon induced by 5-hydroxytryptamine (HT. via 5HT4 and 5HT3 receptors). J Pharmacol Exp Ther 1999, 288:93-97.
37. Sloots CE, Poen AC, Kerstens R, Stevens M, et al.: Effects of prucalopride on colonic transit, anorectal function and bowel habits in patients with chronic constipation. Aliment Pharmacol Ther 2002, 16:759-767.
38. Emmanuel AV, Roy AJ, Nicholls TJ, Kamm MA: Prucalopride, a systemic enterokinetic, for the treatment of constipation. Aliment Pharmacol Ther 2002, 16:1347-1356.
39. Coremans G, Kerstens R, DePauw M, Stevens M: Prucalopride is effective in patients with severe constipation in whom laxatives fail to provide adequate relief. Results of a double-blind, placebo-controlled trial. Digestion 2003, 67:82-89.
40. Ron Y, Avni Y, Luovetski A, et al.: Botulinum toxin type-A in therapy of patients with anismus. Dis Colon Rectum 2001, 44:1821-1826.
41. Verne GN, Davis RH, Robinson ME, et al.: Treatment of chronic constipation with colchicines: randomized, double-blind, placebo-controlled, crossover trial. Am J Gastroenterol 2003, 98:1112-1116.